Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in TD Cowen’s 46th Annual Health Care Conference. Reshma Kewalramani, President and Chief Executive Officer ...
Acticor Sky and Rivacor Sky ICD and CRT‑D Family Integrate Physiological Pacing Strategies with Advanced Arrhythmia ...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...
Instanosis Inc. today announced that its Xylazine Rapid Test (Urine) has been granted Breakthrough Device Designation by the ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the launch of a proposed public offering of $150.0 ...
ISO 42001 audit awards “Best Practice” recognition for Lumanity’s organization-wide approach for safe, transparent and expert ...
NationsBenefits, the leading healthcare fintech and supplemental benefits platform, announced a new partnership with Kinney ...
Regulatory submission is based on positive results from the Phase 2 PROSPECT Study —– FDA sets PDUFA Date of December 18, ...
I’ve spent years studying, writing about, and engaging with leaders across pharmaceuticals, biotechnology, diagnostics, and ...
OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients —SEATTLE--(BUSINESS ...
Oslo, Norway, 17 February 2026 – Oncoinvent, a biotech developing a receptor-independent alpha radiopharmaceutical to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results